Parma Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in Parma
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
Parma News
Data exclusivity will extend pharma monopolies, delay access to affordable medicines, activists say
Activists warn that proposed data exclusivity in India could delay access to affordable medicines and harm the generics industry.
Lupin gets USFDA nod for multiple sclerosis drug
Lupin receives USFDA approval for generic Siponimod Tablets to treat multiple sclerosis, boosting market presence and potential sales.
AI Now Decodes Your Sweat to Spot Early Signs of Disease
Published in the Journal of Pharmaceutical Analysis, the research explores how sweat could be used to follow changes in hormones and other biomarkers in real time, monitor medication levels, and ...
Recent changes to EU chemicals legislation are rarely reflected in the EU pharmaceutical sector
Several changes have been made to EU chemicals policy and legislation with the aim of making society greener. These changes may affect the pharmaceutical sector in many ways, but they are rarely ...